Neulasta
Payments companies reported to CMS as associated with Neulasta. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Neulasta, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Neulasta
These are the largest totals companies reported as associated with Neulasta. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Jan Davis | Ogden, UT | Acute Care (Nurse Practitioner) | $192.76 |
| Ian Flinn | Nashville, TN | Hematology & Oncology | $153.44 |
| Davey Daniel | Chattanooga, TN | Hematology & Oncology | $153.44 |
| Lee Cohen | Two Harbors, MN | Family Medicine | $153.44 |
| Neha Jain | Oakland, CA | Nephrology (Internal Medicine) | $153.44 |
| Jeffrey Patton | Nashville, TN | Medical Oncology | $153.44 |
| Carl Gray | Ogden, UT | Hematology & Oncology | $150.87 |
| Lynn Larsen | Ogden, UT | Nurse Practitioner | $143.85 |
| Anas Aljanadi | Grand Rapids, MI | Medical Oncology | $125.00 |
| Kelly Mikesell | Ogden, UT | Medical | $124.20 |
Prescribed Neulasta?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.